Literature DB >> 30637934

Branched-Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH.

Khalid A Hajj1, Rebecca L Ball1, Sarah B Deluty2,3, Shridhar R Singh1,4, Daria Strelkova1, Christopher M Knapp1, Kathryn A Whitehead1,4.   

Abstract

The potential of mRNA therapeutics will be realized only once safe and effective delivery systems are established. Unfortunately, delivery vehicle development is stymied by an inadequate understanding of how the molecular properties of a vehicle confer efficacy. Here, a small library of lipidoid materials is used to elucidate structure-function relationships and identify a previously unappreciated parameter-lipid nanoparticle surface ionization-that correlates with mRNA delivery efficacy. The two most potent materials of the library, 306O10 and 306Oi10 , induce substantial luciferase expression in mice following a single 0.75 mg kg-1 mRNA dose. These lipidoids, which have ten-carbon tails and identical molecular weights, vary only in that the 306O10 tail is straight and the 306Oi10 tail has a one-carbon branch. Remarkably, this small difference in structure conferred a tenfold improvement in 306Oi10 efficacy. The enhanced potency of this branched-tail lipidoid is attributed to its strong surface ionization at the late endosomal pH of 5.0. A secondary lipidoid library confirms that Oi10 materials ionize more strongly and deliver mRNA more potently than lipidoids containing linear tails. Together, these data highlight the exquisite control that lipid chemistry exerts on the mRNA delivery process and show that branched-tail lipids facilitate protein expression in animals.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  RNA therapeutics; in vivo correlation; ionizable lipids; lipid nanoparticles; mRNA delivery

Year:  2019        PMID: 30637934     DOI: 10.1002/smll.201805097

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  40 in total

Review 1.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

2.  A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo.

Authors:  Khalid A Hajj; Jilian R Melamed; Namit Chaudhary; Nicholas G Lamson; Rebecca L Ball; Saigopalakrishna S Yerneni; Kathryn A Whitehead
Journal:  Nano Lett       Date:  2020-06-09       Impact factor: 11.189

3.  Lipid-Modified Aminoglycosides for mRNA Delivery to the Liver.

Authors:  Xueliang Yu; Shuai Liu; Qiang Cheng; Tuo Wei; Sang Lee; Di Zhang; Daniel J Siegwart
Journal:  Adv Healthc Mater       Date:  2020-02-28       Impact factor: 9.933

Review 4.  RNA delivery biomaterials for the treatment of genetic and rare diseases.

Authors:  Weiyu Zhao; Xucheng Hou; Olivia G Vick; Yizhou Dong
Journal:  Biomaterials       Date:  2019-06-20       Impact factor: 12.479

5.  Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.

Authors:  Margaret M Billingsley; Nathan Singh; Pranali Ravikumar; Rui Zhang; Carl H June; Michael J Mitchell
Journal:  Nano Lett       Date:  2020-02-05       Impact factor: 11.189

6.  Computational and Experimental Approaches to Investigate Lipid Nanoparticles as Drug and Gene Delivery Systems.

Authors:  Chun Chan; Shi Du; Yizhou Dong; Xiaolin Cheng
Journal:  Curr Top Med Chem       Date:  2021       Impact factor: 3.295

7.  Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.

Authors:  Pedro P G Guimaraes; Rui Zhang; Roman Spektor; Mingchee Tan; Amanda Chung; Margaret M Billingsley; Rakan El-Mayta; Rachel S Riley; Lili Wang; James M Wilson; Michael J Mitchell
Journal:  J Control Release       Date:  2019-10-31       Impact factor: 9.776

Review 8.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

9.  Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.

Authors:  Suxin Li; Zachary T Bennett; Baran D Sumer; Jinming Gao
Journal:  Acc Chem Res       Date:  2020-10-16       Impact factor: 22.384

10.  Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing.

Authors:  Shuai Liu; Qiang Cheng; Tuo Wei; Xueliang Yu; Lindsay T Johnson; Lukas Farbiak; Daniel J Siegwart
Journal:  Nat Mater       Date:  2021-02-04       Impact factor: 47.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.